←Hematology & Oncology
Neutropenic fever
📚
📚 Library › 🩸 Hematology & Oncology › Oncologic emergencies
🎗️

Neutropenic fever

A medical emergency — cultures and an anti-pseudomonal β-lactam within 60 minutes, then risk-stratify.

febrile neutropeniaMASCCcefepimeoncology
🗓️ Reviewed 2026-11-18 · ⏱️ 3 min read · 📖 2018 ASCO/IDSA outpatient febrile neutropenia guideline · 2010 IDSA febrile neutropenia guideline · NCCN
🧠 Pathophysiology in 60 seconds🔎 Diagnosis & workup💊 Management⚠️ Pitfalls🎓 Board corner📚 References
⚡ Bottom line — first hour
  • Definition: temp ≥38.3 °C once (or ≥38.0 °C for 1 h) + ANC <500 (or <1000 expected to fall <500).
  • Antibiotics within 60 minutes: cefepime 2 g q8h (or pip-tazo / meropenem). Draw 2 sets of blood cultures first (one from each lumen of a line).
  • Add vancomycin only for: shock, catheter infection, skin/soft-tissue infection, pneumonia, MRSA colonization, gram-positives in blood.
  • Signs of infection may be absent — no neutrophils = no pus, no infiltrate, no pyuria.
  • MASCC ≥21 = low risk → may qualify for oral therapy/outpatient (with oncology).

🧠 Pathophysiology in 60 seconds

⌄
  • Chemotherapy kills fast-dividing cells: neutrophils (nadir day 7–14) and gut lining (mucositis) → gut bacteria translocate.
  • Gram-negative rods (Pseudomonas, E. coli, Klebsiella) kill fastest → the empiric drug must cover Pseudomonas.
  • Longer neutropenia (>7 days) → fungi (Candida, Aspergillus).

🔎 Diagnosis & workup

⌄
  • Full exam: mouth, skin, line sites, perianal area (look, no rectal exam), lungs, sinuses.
  • Labs: CBC with diff, CMP, lactate, blood cultures ×2, UA + urine culture, CXR, respiratory viral PCR as indicated, C. diff if diarrhea.
  • CT chest if respiratory symptoms (CXR is often normal); CT sinuses if symptoms.
MASCC (selected items) Points
Burden of illness: none/mild 5
No hypotension 5
No COPD 4
Solid tumor or no prior fungal infection 4
No dehydration 3
Outpatient at onset 3
Age <60 2
≥21 = low risk

💊 Management

⌄
Situation Regimen
Standard Cefepime 2 g IV q8h · or pip-tazo 4.5 g q6h · or meropenem 1 g q8h
Penicillin allergy (severe) Aztreonam + vancomycin (± aminoglycoside)
Add vancomycin Shock, suspected line infection, SSTI, pneumonia, MRSA colonization, GPC in blood
Abdominal source / C. diff risk Pip-tazo or meropenem (+ oral vanc if C. diff)
Low risk, outpatient (MASCC ≥21) Ciprofloxacin + amoxicillin-clavulanate (if no FQ prophylaxis)
  • Fever 3–5 days is common — do not change antibiotics just for fever if stable.
  • Fever >4–7 days with expected long neutropenia → CT chest, galactomannan/β-D-glucan, start empiric antifungal (voriconazole/echinocandin/liposomal amphotericin).
  • Clinical worsening → broaden (meropenem, + vanc, + antifungal).
  • Unexplained fever: continue until afebrile ≥48 h and ANC recovering (>500) — or stop earlier if clinically stable and afebrile ≥72 h (ECIL-4 approach, with expert input).
  • Documented infection: treat that infection's standard course.
  • G-CSF not routine for established febrile neutropenia (consider in high-risk sepsis).

⚠️ Pitfalls

⌄
  • Waiting for the CBC result before antibiotics in a febrile chemo patient.
  • Rectal temperatures/exams (bacteremia risk).
  • Reflex vancomycin for every case.
  • Forgetting antifungal coverage after a week of fever.

🎓 Board corner

⌄
Stem Answer
Fever 38.6, ANC 200, BP normal Cefepime within 1 h
Same + hypotension Add vancomycin (± broaden to meropenem)
Day 6 of fever, nodules with halo sign on CT Invasive aspergillosis → voriconazole
Neutropenic, RLQ pain, bowel wall thickening Neutropenic enterocolitis (typhlitis)

📚 References

⌄
  • Taplitz RA, et al. Outpatient Management of Fever and Neutropenia: ASCO/IDSA Guideline. J Clin Oncol. 2018;36:1443.
  • Freifeld AG, et al. IDSA Guideline for Neutropenic Patients with Cancer. Clin Infect Dis. 2011;52:e56.
  • Klastersky J, et al. MASCC risk index. J Clin Oncol. 2000.
↩︎ Back to 🩸 Hematology & Oncology